Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15172 | 658 | 39.9 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
876 | 10798 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//ABCG2 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MAJOR VAULT PROTEIN | Author keyword | 33 | 71% | 4% | 27 |
2 | LUNG RESISTANCE RELATED PROTEIN | Author keyword | 26 | 67% | 4% | 24 |
3 | VPARP | Author keyword | 23 | 100% | 2% | 10 |
4 | VAULT COMPLEX | Author keyword | 11 | 100% | 1% | 6 |
5 | LUNG RESISTANCE PROTEIN | Author keyword | 10 | 47% | 2% | 16 |
6 | LRP | Author keyword | 10 | 15% | 9% | 59 |
7 | VAULTS | Author keyword | 9 | 36% | 3% | 20 |
8 | MAJOR VAULT PROTEIN MVP | Author keyword | 7 | 67% | 1% | 6 |
9 | LUNG RESISTANCE RELATED PROTEIN LRP | Author keyword | 6 | 71% | 1% | 5 |
10 | MVP | Author keyword | 6 | 25% | 3% | 21 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MAJOR VAULT PROTEIN | 33 | 71% | 4% | 27 | Search MAJOR+VAULT+PROTEIN | Search MAJOR+VAULT+PROTEIN |
2 | LUNG RESISTANCE RELATED PROTEIN | 26 | 67% | 4% | 24 | Search LUNG+RESISTANCE+RELATED+PROTEIN | Search LUNG+RESISTANCE+RELATED+PROTEIN |
3 | VPARP | 23 | 100% | 2% | 10 | Search VPARP | Search VPARP |
4 | VAULT COMPLEX | 11 | 100% | 1% | 6 | Search VAULT+COMPLEX | Search VAULT+COMPLEX |
5 | LUNG RESISTANCE PROTEIN | 10 | 47% | 2% | 16 | Search LUNG+RESISTANCE+PROTEIN | Search LUNG+RESISTANCE+PROTEIN |
6 | LRP | 10 | 15% | 9% | 59 | Search LRP | Search LRP |
7 | VAULTS | 9 | 36% | 3% | 20 | Search VAULTS | Search VAULTS |
8 | MAJOR VAULT PROTEIN MVP | 7 | 67% | 1% | 6 | Search MAJOR+VAULT+PROTEIN+MVP | Search MAJOR+VAULT+PROTEIN+MVP |
9 | LUNG RESISTANCE RELATED PROTEIN LRP | 6 | 71% | 1% | 5 | Search LUNG+RESISTANCE+RELATED+PROTEIN+LRP | Search LUNG+RESISTANCE+RELATED+PROTEIN+LRP |
10 | MVP | 6 | 25% | 3% | 21 | Search MVP | Search MVP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARCINOMA SW 620 CELLS | 69 | 91% | 4% | 29 |
2 | MAJOR VAULT PROTEIN | 44 | 46% | 11% | 73 |
3 | VPARP | 23 | 100% | 2% | 10 |
4 | RIBONUCLEOPROTEIN PARTICLES | 19 | 21% | 12% | 82 |
5 | RESISTANCE RELATED PROTEIN | 18 | 45% | 5% | 30 |
6 | MRP MESSENGER RNA | 15 | 82% | 1% | 9 |
7 | LUNG RESISTANCE PROTEIN | 15 | 73% | 2% | 11 |
8 | LRP | 13 | 20% | 9% | 58 |
9 | TELOMERASE ASSOCIATED PROTEIN | 11 | 67% | 2% | 10 |
10 | MVP LRP GENE | 11 | 100% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Vaults: a ribonucleoprotein particle involved in drug resistance? | 2003 | 95 | 91 | 80% |
Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity | 2009 | 65 | 152 | 63% |
Cellular functions of vaults and their involvement in multidrug resistance | 2006 | 53 | 159 | 72% |
Development of the Vault Particle as a Platform Technology | 2013 | 11 | 92 | 46% |
Drug resistance: Still a daunting challenge to the successful treatment of AML | 2012 | 38 | 83 | 31% |
The vault complex | 2003 | 54 | 67 | 67% |
MVP and vaults: a role in the radiation response | 2011 | 14 | 101 | 73% |
ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? | 2007 | 55 | 60 | 47% |
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer | 2000 | 99 | 70 | 70% |
Vault ribonucleoprotein particles: Sarcophagi, gondolas, or safety deposit boxes? | 2002 | 61 | 98 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EA 1529 | 2 | 67% | 0.3% | 2 |
2 | FORMAT RECH ASSOCIEE CLAUDE BERNARD TRAITEMENT HE | 2 | 67% | 0.3% | 2 |
3 | AFFILIATED FIRST HOSP | 1 | 50% | 0.2% | 1 |
4 | CANARIAN CANC | 1 | 50% | 0.2% | 1 |
5 | CANAUX ION FONCT PATHOL | 1 | 50% | 0.2% | 1 |
6 | CHAIR HAEMATOL BONE MARROW TRANSPLANTAT | 1 | 50% | 0.2% | 1 |
7 | EMATOL POLICLIN | 1 | 50% | 0.2% | 1 |
8 | FORMAT ASSOCIE RECH CLAUDE BERNARD | 1 | 50% | 0.2% | 1 |
9 | FORMAT RECH ASSOCIEE CLAUDE BERNARD | 1 | 50% | 0.2% | 1 |
10 | GEN SERV CYTOMETRY | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228493 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//PSC 833 |
2 | 0.0000198788 | MRP1//MULTIDRUG RESISTANCE ASSOCIATED PROTEIN//DUBIN JOHNSON SYNDROME |
3 | 0.0000154531 | ABCG2//BCRP//BREAST CANCER RESISTANCE PROTEIN |
4 | 0.0000103324 | ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML |
5 | 0.0000093680 | L1210 CELL LINE//TCRP1//MOL PHYSIOL GENET |
6 | 0.0000085287 | RHEUMATOLOTA KU//MDR I//DANINI HOSP |
7 | 0.0000082225 | PHARMACOEPIGENETICS//ALFRED MED EDUC PROJECT//BANDUNG HOSP |
8 | 0.0000069389 | P GLYCOPROTEIN//C3435T POLYMORPHISM//ABCB1 |
9 | 0.0000054817 | PDXP//SITEP PHASE UNIT 1//DIOC23 |
10 | 0.0000053387 | LEUKEMIA STEM CELLS//EXPT THER EUT TRANSLAT ONCOL PROGRAM//LEUKEMIC STEM CELL |